Milestone: 1,000,000,000 euros.

The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.

Flemming Wagner, CEO and founder, says:

“Abacus Medicine has consistently been among the fastest growing companies in Denmark and in our industry. Our books are not yet closed for the year, but as we pass the 1 billion euro mark we already know that 2022 will be another year of profitable growth for us.

A big thank you and a Merry Christmas to all colleagues and business partners who have brought us here. I look forward to working together to improve global access to medicine again in 2023.”